viewMicro Focus International plc

Micro Focus completes business review, chairman steps down

Chairman Kevin Loosemore stepped down after 15 years in the role as the company posted a 30% drop in annual sales

Micro Focus International plc - Micro Focus completes business review, chairman steps down

Micro Focus International plc (LON:MCRO) has completed a business review and announced the departure of its chairman after a dismal year that saw it demoted from the FTSE 100.

The now FTSE 250-listed software group has made changes to its portfolio that will cost between US$70mln and US$80mln in each of the next two financial years.

In the year to 31 October 2019, the software provider’s revenue tanked 30% to US$3.3bn while adjusted profit before tax slipped 8% to US$984mln.

Sales are expected to drop by a further 6-8% in the current year with margins also under pressure.

“It has certainly not all been smooth sailing over that time but the recent problems can be traced back to the multi-billion dollar acquisition of HP Enterprise in 2017," said AJ Bell's Russ Mould.

"The company has really struggled with the integration of this business and it looks to be firmly in the category of deals which have destroyed rather than created shareholder value."

Chairman Kevin Loosemore’s departure, meanwhile, follows 15 years in the role.

He will be replaced by experienced chair Greg Lock later this month, who will retain a non-executive role.

Lock has more than 45 years of experience in the industry and has been chairman at several companies such as Computacenter plc (LON:CCC), Kofax and SurfControl as well as a director at Informa plc (LON:INF).

Mould commented that Loosemore’s departure could make Micro Focus more vulnerable to an opportunistic bid, since there have been speculations over a potential sale.

The final dividend was increased by 13% to US$1.16 per share.

Shares dropped 11% to 873.4p on Tuesday at the opening bell.

--Adds analyst's comment--

Quick facts: Micro Focus International plc

Price: 250.9 GBX

Market: LSE
Market Cap: £839.05 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


VolitionRx hosts virtual capital markets day event to discuss upcoming...

VolitionRx Limited (NYSE AMERICAN: VNRX) CEO Cameron Reynolds the Austin, Texas-based epigenetics company hosted a virtual capital markets day event on Tuesday, October 20, 2020. Reynolds says the presentation focused on new data, and the launch and commercial roll out of the company's first...

1 hour ago

2 min read